OBJECTIVE: Atherosclerotic coronary artery calcification (CAC) is associated with increased coronary heart disease (CHD) risk. Matrix Gla protein (MGP) is an inhibitor of calcification in vivo. However, little is known regarding the distribution of circulating MGP and its associations with CHD risk factors or with CAC in humans. METHODS AND RESULTS: Serum MGP concentrations were determined in 2 independent populations of men and women free of clinically apparent cardiovascular disease: study A, n=316, mean age 58 years, and study B, n=452, mean age 68 years. CAC was determined by computed tomography. Mean MGP concentrations were 98.4 and 198 ng/mL in men, and 97.4 and 201 ng/mL in women, in study A and study B, respectively. In both cohorts, MGP levels were higher with increasing age. In age-adjusted analyses, there was an association of circulating MGP with increasing Framingham CHD risk score (in study A, P=0.003 in men and P=0.016 in women, respectively; in study B, a nonsignificant increase in men and P=0.05 in women, respectively). Significant associations of circulating MGP with high-density lipoprotein and other individual CHD risk factors were also noted in both cohorts. There were no consistent associations between MGP and CAC after adjustment for CHD risk score in the 2 cohorts. CONCLUSIONS: MGP is associated with individual CHD risk factors and the Framingham CHD risk score in men and women free of clinically apparent CHD. The relation of MGP with CAC deserves further study in larger populations.
OBJECTIVE:Atherosclerotic coronary artery calcification (CAC) is associated with increased coronary heart disease (CHD) risk. Matrix Gla protein (MGP) is an inhibitor of calcification in vivo. However, little is known regarding the distribution of circulating MGP and its associations with CHD risk factors or with CAC in humans. METHODS AND RESULTS: Serum MGP concentrations were determined in 2 independent populations of men and women free of clinically apparent cardiovascular disease: study A, n=316, mean age 58 years, and study B, n=452, mean age 68 years. CAC was determined by computed tomography. Mean MGP concentrations were 98.4 and 198 ng/mL in men, and 97.4 and 201 ng/mL in women, in study A and study B, respectively. In both cohorts, MGP levels were higher with increasing age. In age-adjusted analyses, there was an association of circulating MGP with increasing Framingham CHD risk score (in study A, P=0.003 in men and P=0.016 in women, respectively; in study B, a nonsignificant increase in men and P=0.05 in women, respectively). Significant associations of circulating MGP with high-density lipoprotein and other individual CHD risk factors were also noted in both cohorts. There were no consistent associations between MGP and CAC after adjustment for CHD risk score in the 2 cohorts. CONCLUSIONS:MGP is associated with individual CHD risk factors and the Framingham CHD risk score in men and women free of clinically apparent CHD. The relation of MGP with CAC deserves further study in larger populations.
Authors: H M Spronk; B A Soute; L J Schurgers; J P Cleutjens; H H Thijssen; J G De Mey; C Vermeer Journal: Biochem Biophys Res Commun Date: 2001-11-30 Impact factor: 3.575
Authors: A Farzaneh-Far; J D Davies; L A Braam; H M Spronk; D Proudfoot; S W Chan; K M O'Shaughnessy; P L Weissberg; C Vermeer; C M Shanahan Journal: J Biol Chem Date: 2001-06-25 Impact factor: 5.157
Authors: Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Michelle J Kupka; Warren J Manning; Melvin E Clouse; Ralph B D'Agostino; Peter W F Wilson; Christopher J O'Donnell Journal: Circulation Date: 2002-09-03 Impact factor: 29.690
Authors: Maros Ferencik; Ashley Ferullo; Stephan Achenbach; Suhny Abbara; Raymond C Chan; Sarah L Booth; Thomas J Brady; Udo Hoffmann Journal: Invest Radiol Date: 2003-09 Impact factor: 6.016
Authors: Devyani Misra; Sarah L Booth; Micheal D Crosier; Jose M Ordovas; David T Felson; Tuhina Neogi Journal: J Rheumatol Date: 2011-07-01 Impact factor: 4.666
Authors: M Kyla Shea; Christopher J O'Donnell; Cees Vermeer; Elke J P Magdeleyns; Michael D Crosier; Caren M Gundberg; José M Ordovas; Stephen B Kritchevsky; Sarah L Booth Journal: J Nutr Date: 2011-05-31 Impact factor: 4.798
Authors: Kathryn P Burdon; Megan E Rudock; Allison B Lehtinen; Carl D Langefeld; Donald W Bowden; Thomas C Register; Yongmei Liu; Barry I Freedman; J Jeffrey Carr; Catherine C Hedrick; Stephen S Rich Journal: Mediators Inflamm Date: 2010-05-31 Impact factor: 4.711
Authors: Michael D Crosier; Sarah L Booth; Inga Peter; Bess Dawson-Hughes; Paul A Price; Christopher J O'Donnell; Udo Hoffmann; Matthew K Williamson; Jose M Ordovas Journal: J Nutr Sci Vitaminol (Tokyo) Date: 2009-02 Impact factor: 2.000
Authors: M Kyla Shea; Christopher J O'Donnell; Udo Hoffmann; Gerard E Dallal; Bess Dawson-Hughes; José M Ordovas; Paul A Price; Matthew K Williamson; Sarah L Booth Journal: Am J Clin Nutr Date: 2009-04-22 Impact factor: 7.045
Authors: Benjamin D Parker; Joachim H Ix; Ellen C M Cranenburg; Cees Vermeer; Mary A Whooley; Leon J Schurgers Journal: Nephrol Dial Transplant Date: 2009-02-09 Impact factor: 5.992